Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
JBIO is expected to report earnings to fall 97.41% to -31 cents per share on August 11
Q2'25
Est.
$-0.31
Q1'25
Missed
by $11.69
Q4'24
Missed
by $6.21
The last earnings report on May 19 showed earnings per share of -1210 cents, missing the estimate of -41 cents. With 46.16K shares outstanding, the current market capitalization sits at 284.00M.